Case Number 3699
Request Date 11/07/2014
Completion Date 14/07/2014

 

Details of the Request

How many patients with Multiple Sclerosis are currently being treated with the following drugs;

  • Interferon beta-1a [Avonex or Rebif]
  • Interferon beta-1b [Extavia or Betaferon]
  • Glatiramer acetate [Copaxone]
  • Natalizumab [Tysabri]
  • Fingolimod [Gilenya]
  • Alemtuzumab [Lemtrada]
  • Dimethyl fumarate [Tecfidera]
  • Teriflunomide [Aubagio]
  • Other

 

If possible please complete the following table:

Drug Name Brand Name Number of Patients
Interferon beta-1a Avonex  
Interferon beta-1a Rebif  
Interferon beta-1b Extavia  
Interferon beta-1b Betaferon  
Glatiramer acetate Copaxone  
Natalizumab Tysabri  
Fingolimod Gilenya  
Alemtuzumab Lemtrada  
Dimethyl fumarate Tecfidera  
Teriflunomide Aubagio  
Other    
TOTAL    

 

Details of the Response

Drug Name Brand Name Number of Patients
Interferon beta-1a Avonex  29
Interferon beta-1a Rebif  31
Interferon beta-1b Extavia  0
Interferon beta-1b Betaferon  2
Glatiramer acetate Copaxone  60
Natalizumab Tysabri  14
Fingolimod Gilenya  19
Alemtuzumab Lemtrada 0
Dimethyl fumarate Tecfidera  0
Teriflunomide Aubagio  3
Other    0
TOTAL    158